Jean François Seitz

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro et al. · New England Journal of Medicine · 2008 · 13K citations · Full text

Medicine, Oncology, Pharmacology +12

Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?

Sharlene Gill, Charles L. Loprinzi, Daniel J. Sargent et al. · Journal of Clinical Oncology · 2004 · 1K citations

Medicine, Oncology, Chemotherapy +16

A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients

Daniel J. Sargent, Richard M. Goldberg, Stacy D. Jacobson et al. · New England Journal of Medicine · 2001 · 994 citations · Full text

Medicine, Geriatric Medicine, Oncology +15

Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials

Daniel J. Sargent, Harry S. Wieand, Daniel G. Haller et al. · Journal of Clinical Oncology · 2005 · 712 citations · Full text

Medicine, Biostatistics, Oncology +17

Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials

Daniel J. Sargent, Alberto Sobrero, Axel Grothey et al. · Journal of Clinical Oncology · 2009 · 676 citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +15